Scarica l'app Stockscreener
3.89
7.82%
-0.33
Dopo l'orario di chiusura:
3.94
0.05
+1.29%
Precedente Chiudi:
$4.22
Aprire:
$4.27
Volume 24 ore:
1.28M
Relative Volume:
0.87
Capitalizzazione di mercato:
$50.42M
Reddito:
$128.60K
Utile/perdita netta:
$-4.60M
Rapporto P/E:
-11.11
EPS:
-0.35
Flusso di cassa netto:
$-3.74M
1 W Prestazione:
+16.47%
1M Prestazione:
+208.73%
6M Prestazione:
+196.95%
1 anno Prestazione:
+1,180%
Intervallo 1D:
$3.65
$4.27
Intervallo di 1 settimana:
$3.03
$4.36
Portata 52W:
$0.2528
$4.36
Nexalin Technology Inc Stock (NXL) Company Profile
Nome
Nexalin Technology Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta NXL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| NXL | 3.89 | 50.42M | 128.60K | -4.60M | -3.74M | -0.35 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Nexalin Technology Inc Borsa (NXL) Ultime notizie
Nexalin Technology stock soars to all-time high of $4.07 - Investing.com
Nexalin Technology stock soars to all-time high of $4.07 By Investing.com - Investing.com UK
Nexalin Technology CEO Provides Letter to Shareholders - GlobeNewswire
Nexalin's Breakthrough: Alzheimer's Studies Show Promise, Secures Key Brain Tech Patent | NXL Stock News - StockTitan
Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth? - Yahoo Finance
Nexalin Technology’s Strong Financial Position: No Defaults on Senior Securities - TipRanks
Nexalin Technology Inc (NXL) Quarterly 10-Q Report - Quartzy
Nexalin regains Nasdaq compliance with bid price rule By Investing.com - Investing.com Australia
Nexalin regains Nasdaq compliance with bid price rule - Investing.com India
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th - GlobeNewswire
Nexalin Technology : Regains Compliance with Nasdaq Continued Listing Requirements Form 8 K - Marketscreener.com
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements - The Manila Times
LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
Nexalin technology's chief medical officer buys $1,095 in stock By Investing.com - Investing.com Canada
Nexalin technology's chief medical officer buys $1,095 in stock - Investing.com India
Significant Stock Increase For Nexalin (NXL) After Alzheimer’s Study Announcement - Stocks Telegraph
EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients - AOL
Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease - The Manila Times
Nexalin Technology Announces Landmark Study on Alzheimer's - GlobeNewswire
EXCLUSIVE: Nexalin Technology Says New Data Confirms Investigational Non-Invasive Neurostimulation Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients (UPDATED) - Benzinga
Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
Pre-Market Gains For Nexalin (NXL) Driven By Upcoming Clinical Trial - Stocks Telegraph
Nexalin trials Halo neurostimulation device in traumatic brain injury - Yahoo Finance
NXLNexalin Technology, Inc. Latest Stock News & Market Updates - StockTitan
Nexalin Technology Announces Planned Clinical Trial - GlobeNewswire
Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership - The Bakersfield Californian
Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA - StockTitan
Mixed results for Nexalin’s transcranial alternating current stimulation trial - Yahoo Finance
New Study Shows Nexalin’s Deep Intracranial Frequency - GlobeNewswire
New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients - StockTitan
EXCLUSIVE: Nano-Cap Nexalin's Drug-Free Alternative For Alzheimer's Shows Improved Memory, Cognitive Function In Small Study - Benzinga
Nexalin Technology Inc [NXL] Investment Guide: What You Need to Know - Knox Daily
NXL: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle
Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs - GlobeNewswire
Nexalin Technology Inc’s latest rating changes from various analysts - Knox Daily
Nexalin Technology : HALO Global Regulatory Strategy Presentation - Marketscreener.com
Neta X Launch Date Revealed, Price Of IDR 400 Million? - VOI English
World of light and colour on its way to city centre - Newark Advertiser
NEXT Biometrics Expands in India with New Order - TipRanks
Business News | Content-sharing Startup Newzo Mobile App Gets Seed Funding by Concept PR Mumbai - LatestLY
Tetra Pak and NIFTEM Sign MoU to Advance Food Processing Innovation in India - ThePrint
Content-Sharing Startup Newzo Mobile App Gets Seed Funding By Concept PR Mumbai - Zee News
Nexalin Technology Welcomes New SVP Carolyn Shelton - TipRanks
This smallcap IT stock gave 191% returns in last one year, hits new all-time high; here's why - Upstox
Nexalin Technology Inc (NXL) Stock: A Year of Declines and Increases - The InvestChronicle
Daily Progress: Nexalin Technology Inc (NXL) Drop -10.32, Closing at 0.85 - The Dwinnex
Nexalin Technology Participates in Congressional Roundtable - GlobeNewswire
Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment - StockTitan
Nexalin Technology Inc Azioni (NXL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
0.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):